SK280111B6 - Použitie ropivakaínu na výrobu farmaceutického pro - Google Patents

Použitie ropivakaínu na výrobu farmaceutického pro Download PDF

Info

Publication number
SK280111B6
SK280111B6 SK1646-95A SK164695A SK280111B6 SK 280111 B6 SK280111 B6 SK 280111B6 SK 164695 A SK164695 A SK 164695A SK 280111 B6 SK280111 B6 SK 280111B6
Authority
SK
Slovakia
Prior art keywords
ropivacaine
pain
infusion
motor
block
Prior art date
Application number
SK1646-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK164695A3 (en
Inventor
Arne Torsten Eek
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK280111(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of SK164695A3 publication Critical patent/SK164695A3/sk
Publication of SK280111B6 publication Critical patent/SK280111B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Steroid Compounds (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
  • Air Conditioning Control Device (AREA)
  • Electromechanical Clocks (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SK1646-95A 1993-06-28 1994-05-26 Použitie ropivakaínu na výrobu farmaceutického pro SK280111B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (2)

Publication Number Publication Date
SK164695A3 SK164695A3 (en) 1996-07-03
SK280111B6 true SK280111B6 (sk) 1999-08-06

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1646-95A SK280111B6 (sk) 1993-06-28 1994-05-26 Použitie ropivakaínu na výrobu farmaceutického pro

Country Status (32)

Country Link
US (2) US5670524A (OSRAM)
EP (1) EP0706395B1 (OSRAM)
JP (1) JP3725541B2 (OSRAM)
CN (1) CN1074918C (OSRAM)
AT (1) ATE216237T1 (OSRAM)
BR (1) BR9406865A (OSRAM)
CA (1) CA2165446C (OSRAM)
CZ (1) CZ283300B6 (OSRAM)
DE (2) DE706395T1 (OSRAM)
DK (1) DK0706395T3 (OSRAM)
EE (1) EE03205B1 (OSRAM)
ES (1) ES2099048T3 (OSRAM)
FI (1) FI956269A0 (OSRAM)
GR (1) GR970300013T1 (OSRAM)
HU (1) HU218949B (OSRAM)
IL (1) IL110006A (OSRAM)
IS (1) IS4174A (OSRAM)
LT (1) LT3449B (OSRAM)
LV (1) LV12918B (OSRAM)
MY (1) MY119360A (OSRAM)
NO (1) NO955313D0 (OSRAM)
NZ (1) NZ268110A (OSRAM)
PH (1) PH31258A (OSRAM)
PL (1) PL175518B1 (OSRAM)
PT (1) PT706395E (OSRAM)
RU (1) RU2152215C1 (OSRAM)
SA (1) SA94150010B1 (OSRAM)
SE (1) SE9302218D0 (OSRAM)
SG (1) SG49078A1 (OSRAM)
SK (1) SK280111B6 (OSRAM)
TW (1) TW285640B (OSRAM)
WO (1) WO1995000148A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
AU742488B2 (en) * 1997-07-21 2002-01-03 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
EP2209450A4 (en) * 2007-11-07 2013-09-25 Svip5 Llc SLOW RELEASE OF LOCAL ANESTHESIC ORGANIC SALTS FOR PAIN RELIEF
CA2871820C (en) * 2012-05-10 2020-11-03 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
KR102377252B1 (ko) 2013-02-28 2022-03-22 저니 메디컬 코퍼레이션 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000599A1 (en) * 1983-08-01 1985-02-14 A/S Apothekernes Laboratorium For Specialpraeparat L-N-n-PROPYLPIPECOLIC ACID-2,6-XYLIDIDE AND METHOD FOR PREPARING THE SAME
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
HU9503692D0 (en) 1996-02-28
DE706395T1 (de) 1997-09-04
JPH09500620A (ja) 1997-01-21
GR970300013T1 (en) 1997-05-31
DK0706395T3 (da) 2002-07-22
SE9302218D0 (sv) 1993-06-28
NZ268110A (en) 1999-06-29
EE03205B1 (et) 1999-08-16
AU7086694A (en) 1995-01-17
MY119360A (en) 2005-05-31
CA2165446C (en) 2005-07-05
ATE216237T1 (de) 2002-05-15
SG49078A1 (en) 1998-05-18
SK164695A3 (en) 1996-07-03
FI956269A7 (fi) 1995-12-27
NO955313L (no) 1995-12-27
US5670524A (en) 1997-09-23
SA94150010B1 (ar) 2006-04-04
PL175518B1 (pl) 1999-01-29
HU218949B (hu) 2001-01-29
CN1074918C (zh) 2001-11-21
US5834489A (en) 1998-11-10
EP0706395A1 (en) 1996-04-17
IS4174A (is) 1994-12-29
LV12918B (en) 2003-03-20
DE69430427T2 (de) 2002-11-14
PL312198A1 (en) 1996-04-01
CZ336495A3 (en) 1996-06-12
LTIP1958A (en) 1995-01-31
NO955313D0 (no) 1995-12-27
BR9406865A (pt) 1996-03-26
WO1995000148A1 (en) 1995-01-05
CZ283300B6 (cs) 1998-02-18
PH31258A (en) 1998-06-18
TW285640B (OSRAM) 1996-09-11
ES2099048T1 (es) 1997-05-16
LT3449B (en) 1995-10-25
RU2152215C1 (ru) 2000-07-10
EP0706395B1 (en) 2002-04-17
FI956269L (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
HUT75115A (en) 1997-04-28
FI956269A0 (fi) 1995-12-27
ES2099048T3 (es) 2002-11-16
DE69430427D1 (de) 2002-05-23
JP3725541B2 (ja) 2005-12-14
PT706395E (pt) 2002-09-30
CN1126435A (zh) 1996-07-10
IL110006A (en) 1999-01-26
AU692161B2 (en) 1998-06-04
IL110006A0 (en) 1994-11-11
CA2165446A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
AU2019257386B2 (en) Extended duration local anesthetic formulation
Törn et al. Effects of sub-hypnotic doses of propofol on the side effects of intrathecal morphine
Aida et al. Involvement of presurgical pain in preemptive analgesia for orthopedic surgery: a randomized double blind study
JP2001513814A (ja) 小児科手術におけるレボブピバカインの使用
Nuuttnen et al. Diclofenac and oxycodone in treatment of postoperative pain: a double‐blind trial
Pitkänen et al. Effect of tropisetron, a 5-HT3 receptor antagonist, on analgesia and nausea after intrathecal morphine
SK280111B6 (sk) Použitie ropivakaínu na výrobu farmaceutického pro
KR20170066549A (ko) 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여
Domsky et al. Patient-controlled spinal analgesia for postoperative pain control
AU692161C (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
Atallah et al. Presurgical analgesia in children subjected to hypospadias repair
KR102118227B1 (ko) 척추 투여용 과포화 아세타미노펜 주사 용액
Raksamani et al. A comparison of etidocaine and lidocaine in epidural analgesia for surgery
Selander Ropivacaine (Naropin®), a new local anesthetic for anaesthesia and analgesia
HK1010344B (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
HK1235300A1 (en) Co-administration of intravenous ibuprofen and acetaminophen for treatment of pain
MXPA99008057A (en) The use of levobupivacaine in paediatric surgery

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100526